Research on Pei Zhengxue's Formulation Series

1 Conclusions

Chapter 231

1.1 Pei’s Soft Liver and Anti-Bloating Pills can significantly inhibit the growth of tumors in tumor-bearing mice, slowing down the rate of tumor growth and demonstrating remarkable anti-tumor pharmacological effects, co

From Research on Pei Zhengxue's Formulation Series · Read time 7 min · Updated March 22, 2026

Keywords方药研究, 实验研究, 配方资产, 转化沟通, 2 体会与展望

Section Index

  1. 1 Conclusions

1 Conclusions

1.1 Pei’s Soft Liver and Anti-Bloating Pills can significantly inhibit the growth of tumors in tumor-bearing mice, slowing down the rate of tumor growth and demonstrating remarkable anti-tumor pharmacological effects, consistent with the clinical efficacy achieved over many years of use.

1.2 These pills can markedly improve the thymus index and spleen index in tumor-bearing mice, thereby enhancing their non-specific immune function.

1.3 Pei’s Soft Liver and Anti-Bloating Pills can increase the levels of TNF-α and IFN-γ in serum, suggesting that they regulate the body’s immune function by influencing cytokines, which is also one of the possible pathways through which these pills exert their anti-tumor effects.

In conclusion, by measuring macroscopic indicators such as tumor weight, thymus size, and spleen size in tumor-bearing mice, as well as observing microscopic indicators like TNF-α and IFN-γ, experiments have proven that Pei’s Soft Liver and Anti-Bloating Pills inhibit tumor growth by regulating the immune function of the mice themselves, improving their quality of life, and achieving good therapeutic results.

This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.